Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Medx Health acquires Canadian operations of Reimers & Janssen GmbH

MedX Health Corp., a global leader in drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced it has acquired the Canadian operations of 27 year old laser pioneer, Reimers & Janssen GmbH (herein after "RJ-Laser"), providing an expanded line of products, with improved product features, within MedX's existing rehab/chiropractic, dental, and acupuncture laser and light markets, as well as approved products ready for launch to Veterinarians and Dermatologists.

23 Mar 2010

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.

23 Mar 2010

Aureus Pharma to participate in € 118 million BioIntelligence R&D programme

Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today it’s participation in a EUR118.2 million (USD 160 million) project. The project is the Biointelligence R&D programme designed to promote the use of systemic modeling and simulation tools to exploit biomedical databases to improve research efficiency.

23 Mar 2010

Inhibitex announces net loss of $4.7M for fourth-quarter 2009

Inhibitex, Inc. today announced its financial results for the fourth quarter and year ended December 31, 2009 and provided an update on various corporate developments.

23 Mar 2010

Perrigo signs definitive merger agreement to acquire PBM Holdings for $808M in cash

Perrigo Company today announced that it has signed a definitive merger agreement to acquire PBM Holdings, Inc. (PBM), the leading store-brand infant formula manufacturer, for approximately $808 million in cash. Based in Gordonsville, Virginia, privately-held PBM manufactures and distributes over-the-counter store brand infant formula and baby foods sold by leading retailers in the mass, club, grocery and drug channels in the United States, Canada, Mexico and China. The acquisition is expected to close in the Company's fiscal 2010 fourth quarter pending regulatory approval.

23 Mar 2010

Researchers investigate link between consumption of high-fructose corn syrup and obesity

A Princeton University research team has demonstrated that all sweeteners are not equal when it comes to weight gain: Rats with access to high-fructose corn syrup gained significantly more weight than those with access to table sugar, even when their overall caloric intake was the same.

23 Mar 2010

New, biodegradable biomaterial that promotes bone growth

Screws used in surgical operations are often made of titanium. They usually have to be removed after a while or replaced by new ones. A new biomaterial makes this unnecessary. It promotes bone growth and is biodegradable.

23 Mar 2010

GSK notifies regulatory authorities of the presence of PCV-1 in Rotarix vaccine

GlaxoSmithKline today confirmed that it has notified regulatory authorities of the presence of material from a virus called PCV-1 in its oral rotavirus vaccine, Rotarix™. PCV-1 does not multiply in humans and is not known to cause illness in humans.

23 Mar 2010

DSM Biomedical expands resources and operations in the U.S. and Europe

DSM Biomedical, a global leader in biomedical materials science, today announced the expansion of its resources and operations in the United States and Europe to support the growing demand for the company’s portfolio of innovative polyurethanes for chronically implanted medical devices in the regions.

23 Mar 2010

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the pending commercial launch of 13 new SFDA approved products over the next few quarters.

22 Mar 2010

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.

22 Mar 2010

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).

22 Mar 2010

Given Imaging to purchase Sierra Scientific Instruments from Water Street Healthcare Partners for $35M

Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care, announced today that it has entered into a definitive agreement to sell its gastrodiagnostic device company, Sierra Scientific Instruments, to Given Imaging Ltd ( GIVN). Given Imaging, the global leader in patient-friendly GI diagnostic and monitoring solutions, will purchase the business for $35 million in cash. The transaction is expected to close in early April.

22 Mar 2010

Sorin Group reports consolidated revenues of € 689.0M for 2009

“The final 2009 financial statements confirm the full achievement of our targets; this solid financial basis will be the foundation for future growth. The 2010-2014 Plan confirms the strategic guidelines previously communicated, based on profitability and cash flow expansion and prepares for accelerated growth in the future” said André-Michel Ballester, Chief Executive Officer, Sorin Group.

20 Mar 2010

Impact of plastics on human health and ecosystems

Plastics surround us. A vital manufacturing ingredient for nearly every existing industry, these materials appear in a high percentage of the products we use every day. Although modern life would be hard to imagine without this versatile chemistry, products composed of plastics also have a dark side, due in part to the very characteristics that make them so desirable-their durability and longevity.

20 Mar 2010

China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the receipt of Conformite Europeenne (CE) certification for its Myocardial Infarction and Urine Microalbumin Diagnostic Kits. The CE marking certifies that the two products have met the European Union health and safety standards and are approved for sale in the 27 EU countries and four members of the European Free Trade Association.

20 Mar 2010

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Valeant Pharmaceuticals International advances dermatology presence in Brazilian market

Valeant Pharmaceuticals International today announced that it has signed a binding agreement to acquire a private branded generics and over the counter company located in Brazil for approximately US$28 million. A large portion of the company's product portfolio is in dermatology and the company had annual sales of approximately US$19 million in 2009.

19 Mar 2010

A.P. Pharma's NDA for APF530 in prevention of CINV: FDA issues Complete Response Letter

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for APF530 in the prevention of both acute and delayed onset chemotherapy-induced nausea and vomiting.

19 Mar 2010

Stemedica files IND for trial using allogeneic mesenchymal bone marrow cells in patients with ischemic stroke

Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

19 Mar 2010

Manufacturing News and Research

Further Reading

Medx Health acquires Canadian operations of Reimers & Janssen GmbH

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

Aureus Pharma to participate in € 118 million BioIntelligence R&D programme

Inhibitex announces net loss of $4.7M for fourth-quarter 2009

Perrigo signs definitive merger agreement to acquire PBM Holdings for $808M in cash

Researchers investigate link between consumption of high-fructose corn syrup and obesity

New, biodegradable biomaterial that promotes bone growth

GSK notifies regulatory authorities of the presence of PCV-1 in Rotarix vaccine

DSM Biomedical expands resources and operations in the U.S. and Europe

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Given Imaging to purchase Sierra Scientific Instruments from Water Street Healthcare Partners for $35M

Sorin Group reports consolidated revenues of € 689.0M for 2009

Impact of plastics on human health and ecosystems

China Sky One Medical's Myocardial Infarction and Urine Microalbumin Diagnostic Kits receive CE certification

Pressure BioSciences announces presentations on advantages of PCT

Valeant Pharmaceuticals International advances dermatology presence in Brazilian market

A.P. Pharma's NDA for APF530 in prevention of CINV: FDA issues Complete Response Letter

Stemedica files IND for trial using allogeneic mesenchymal bone marrow cells in patients with ischemic stroke

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News